While not FDA-approved in compounded form, your provider can help determine if these treatments are right for you
BPC-157 may also enhance the migration of tendon fibroblasts, as indicated by the transwell filter migration assay used in the study
A subcutaneous injection, which goes into the fatty tissue just beneath the skin, provides a slower, more gradual release
Unknown Long-Term Effects : Long-term impact on organs, metabolic function, and disease risk has not been established, which creates uncertainty about chronic use
Tirzepatide Once Weekly for the Treatment of Obesity: Participants in this study complete a 60-week Weight-Loss Period on Tirzepatide, followed by a 52-week Weight Maintenance Period, where they are assigned to either Tirzepatide 5 mg, the maximum tolerated dose of Tirzepatide, and saw successful results